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Expression of 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein in
Immune Cells
Huan Ma, Liheng Guo, Shiyu Ma, Xin Huang, Yanfen Chen,
Minzhou Zhang
Guangdong Provincial Hospital of Traditional Chinese Medicine
OBJECTIVES Arachidonic acid (AA), an omega-6 (n-6) fatty acid, can
be converted to inﬂammatory leukotrienes (LTs) by 5-lipoxygenase (5-
LO), which is activated by 5-lipoxygenase-activing protein (FLAP) and
then lead to the expression of LTB4, which play a role in coronary
heart disease (CHD).omega-3 (n-3) fatty acids are the metabolic
counterparts to n-6 fatty acids and have anti-inﬂammatory effects.
Thus, the tissue ratio of n-6/n-3 fatty acids may inﬂuence LT pro-
duction. However, whether alteration of tissue n-6/n-3 fatty acid ratio
has an effect on 5-LO and FLAP expression is not well known. The fat-
1 transgenic mouse, expressing an n-3 fatty acid desaturase, is capable
of endogenously converting n-6 fatty acids to n-3 fatty acids, and
thereby has a tissue n-6/n-3 fatty acid ratio close to 1:1. The aim of the
study was to compare 5-LO and FLAP expression status in immune
cells between fat-1 transgenic mice and wild type (WT) littermates.
METHODS Immune cells from fat-1 transgenic mice (n¼5) and WT
mice (n¼5) were harvested from the spleen and cultured for 24h.
Mononuclear cells were also isolated from the blood. Cellular n-6/n-3
fatty acid proﬁles were analyzed using gas chromatography. The
mRNA and protein expressions of 5-LO and FLAP in the cells were
evaluated using real time RT-PCR and immunoblot (WB) assays,
respectively. the expression of LTB4 level was assessed by Elisa assay.
RESULTS He fat-1 transgenic mice showed a lower ratio of n-6/n-3
fatty acids than WT mice in both splenocytes and blood monocytes
(AA: 4.530.10 VS 2.160.09; EPA: 0.130.07 VS 0.360.15; DHA:
0.490.14 VS 2.170.76; Total u-3: 0.680.29 VS 2.660.70; u-6/u-3:
9.494.70 VS 1.320.36). The mRNA expressions of 5-LO and FLAP
were signiﬁcantly lower in the cells of fat-1 mice than in those of WT
mice. Accordingly, the protein levels of 5-LO and FLAP were also
markedly lower in fat-1 mice than in WT mice. The LTB4 level was also
lower in fat-1 mice than WT mice.
CONCLUSIONS Our ﬁndings demonstrate that a decreased tissue n-6/
n-3 fatty acid ratio reduces 5-LO and FLAP expression. This study
suggests a role for tissue n-6/n-3 fatty acid ratio in the 5-LO pathway
of AA metabolism in immune cells, and a new mechanism for the anti-
inﬂammatory effect of n-3 fatty acids, omega-3 fatty acid may play a
role in the prevention of CHD.
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A prescription of Jiashen reduces postinfarct left ventricular remodeling
via inhibition of TGF-b/Smads signaling pathway
Yuan Gao, Shiyang Xie, Youping Wang, Bin Li, Xiaoli Nan,
Weihong Liu, Mingjun Zhu
First Afﬁliated Hospital, Henan University of Traditional Chinese
Medicine
OBJECTIVES To explore the mechanisms underlying A prescription of
Jiashen(PJS)-mediated cardioprotection, we determined whether PJS
reduces early left ventricular remodeling via inhibiting TGF-b/Smads
signaling pathway in a rat model of myocardial infarction(MI).
METHODS Male Sprague-Dawley rats were subjected to sham-
operation orMI by ligating the left anterior descending coronary artery.
The rats withMI were treated with vehicle, PJS at the dose of 3 g/kg/day
and 6 g/kg/day, or losartan at the dose of 10mg/kg/day 24h afterMI. The
rats in the vehicle group and the sham-operation group were intra-
gastrically given at the same dosage of normal saline. One weeks later,
we determined the effects of PJS and losartan on cardiac function, and
the distribution and level of collagen using echocardiography, Mas-
son’s trichrome stain and hydroxyproline assay, respectively. The
myocardial expression of TGF-b/Smads signaling pathway was deter-
mined by the use of Western blot.
RESULTS Compared to MIþvehicle rats, PJS at the dose of 6g/kg/day
reduced the increases in left ventricular end-diastolic dimension
(0.820.04 vs. 0.660.04 cm, P<0.05) and left ventricular end-systolic
dimension (0.610.03 vs. 0.400.04 cm, P<0.05), and the decreases in
ejection fraction(55.264.60% vs. 70.755.61%, P<0.05) and fractional
shortening (25.682.91% vs. 36.69 3.94%, P<0.05) at week 1 after MI.
In addition, treatment with PJS at the dose of 6 g/kg/day inhibited the
increased levels of collagen (10.840.79vs. 16.751.53 pg/mg protein,
P<0.05) and the expression of transforming growth factor-b1(TGF-b1),
phosphorylated Smad 2(p-Smad 2), and phosphorylated Smad
3(p-Smad 3) compared to MIþvehicle rats at week 1 after MI (TGF-b1:1.060.01 vs. 1.39 0.01%GAPDH arbitrary units; p-Smad 2: 1.520.00
vs. 2.06 0.03% GAPDH arbitrary units; p-Smad 3: 0.500.00 vs.
1.050.01% GAPDH arbitrary units, P<0.05). Losartan treatment has
the similar results with PJS at the dose of 6 g/kg/day.
CONCLUSIONS Our data demonstrated that PJS treatment improved
cardiac function, and reduced myocardial ﬁbrosis at the early stage of
MI. The results were associated with the inhibition of the expression
of TGF-b/Smads signaling expression. Our results suggest that PJS
may improve left ventricular remodeling possibly via attenuating
TGF-b/Smads signaling pathway in the early period of MI.
[This work was supported by a grant from the National Natural
Science Foundation of China (No. 81173410)].
GW26-e1430
Fufangxueshuantong ameliorates diabetic cardiomyopathy in rats by
attenuating cardic and metabolic dysfunction
Jing Han, Yan Wu, Tiantian Lv, Hongliang Wang, Gaimei Hao, Jie He,
Wei Wang
Beijing University of Chinese Medicine
OBJECTIVES Diabetic cardiomyopathy (DCM) can cause diastolic and
systolic dysfunction damage, resulting in myocardial ischemia and heart
failure. Fufangxueshuantong (FXST), which is composed of Panax noto-
ginseng, Salvia miltiorrhiza, Astragalus membranaceus and Scrophularia
ningpoensis, has been used for the treatment of angina pectoris and dia-
betic retinopathy for years. However, whether FXST has an effect on DCM
is unknown. Metabolic dysfunction occurs in hearts and contributes to
DCM. Adenosine monophosphate-activated protein kinase (AMPK),
peroxisome proliferator activated receptorg coactivator 1 (PGC1a) and si-
lent information regulator 1(sirt1) signaling pathways sense the metabolic
demands and impinge on expression of genes encoding for metabolic
enzymes (citrate synthase(CS), etc). So the present study aims to demon-
strate that whether FXST treatment can ameliorate cardiac function in
diabetic rats and to illustrate its effect on energy metabolic mechanism.
METHODS SD rats were randomly divided into 3 groups: normal
group, diabetic group, diabeticþFXST group. 20 weeks after strepto-
zocin induction, FXST or water was administered for 16 weeks. Car-
diac dimensions and function were determined by echocardiography.
Left ventricular internal diameter during diastole (LVIDd) and systole
(LVIDs) were assessed in M-mode, and ejection fraction (EF), frac-
tional shortening (FS) and left ventricular mass (LV mass) were
calculated with the M-mode measurements. Doppler echocardiogra-
phy was used to measure IVRT (Isovolumic relaxation time) and E/A
(Ratio of peak early to late transmitral blood ﬂow velocities). After
echocardiographic detection, the indicators of energy metabolism (CS,
AMPK, PGC1a, sirt1) in hearts were detected through PCR.
RESULTS Echocardiography revealed that in the diabetic group, a
decrease in E/A and an increase in IVRT were observed in the rats (vs.
normal group). Following treatment with FXST in the diabetic rats, E/A
was found to be upregulated, (vs. diabetic group). In the diabetic group,
a decrease in EF, FS, LV mass and an increase in LVIDd, LVIDs were
observed in the rats (vs. normal group). Following treatment with FXST
in the diabetic rats, EF and FS were found to be upregulated, while
LVIDd and LVIDs were markedly decreased (vs. diabetic group).
Real time PCR analysis revealed decreased content of PGC1a, sirt1
and increased levels of CS, AMPK in the diabetic group when
compared with the normal group. However, increased levels of (CS,
AMPK, PGC1a, sirt1) were observed in the FXST-treated group when
compared with the diabetic group.
CONCLUSIONS Our study demonstrated that diabetes induced diabetic
cardiomyopathy, characterized by both diastolic and systolic dysfunc-
tion and metabolic dysfunction in heart. And FXST protected DCM via
attenuating cardiac function. In addition, therapeutic FXST administra-
tion can promote gene levels of energy metabolism. These ﬁndings pro-
vide evidence as to the cardiac protective efﬁcacy of FXST to DCM.
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Cardioprotective effect of propofol against oxygen glucose deprivation
and reperfusion injury in H9c2 cells
Dandan Zhao,1 Jiang Hong1,2
1Shanghai General Hospital, Shanghai Jiao Tong University; 2School of
Pharmacy, Shanghai Jiao Tong University
OBJECTIVES The intravenous anesthetic propofol is reported to be a
cardioprotective agent against ischemic-reperfusion injury in the
heart. However, the regulatory mechanism still remains unclear.
METHODS In the study, we used H9c2 cell line under condition of
oxygen glucose deprivation (OGD) followed by reperfusion (OGD/R) to
